金河生物控股股东拟减持 2021年定增募资8.2亿元

Group 1 - The controlling shareholder, Inner Mongolia Jinhai Holdings Co., Ltd., plans to reduce its stake in Jinhai Biological by up to 22,563,389 shares, representing no more than 3% of the total share capital [1] - The reduction will occur within three months from June 10, 2025, to September 9, 2025, through centralized bidding and block trading [1] - The reason for the share reduction is to repay pledged debts, with shares originating from a previous restructuring and capital increases [1] Group 2 - In a previous non-public offering on August 10, 2021, Jinhai Biological issued 145,132,743 shares at a price of 5.65 yuan per share, raising approximately 820 million yuan [2] - After deducting issuance costs, the net funds raised amounted to approximately 802 million yuan, with 145 million yuan allocated to share capital and over 657 million yuan to capital reserves [2]